Bacitracin (Akorn, Inc.)


Welcome to the PulseAid listing for the Bacitracin drug offered from Akorn, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Bacitracin
SUBSTANCE NAME: BACITRACIN A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-23
END MARKETING DATE: 0000-00-00


Bacitracin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBacitracin from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 5000([USP’U]/mL)
START MARKETING DATE: 2017-10-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-608_bb0e2e1d-ff83-43ed-a9be-4339d1226f32
PRODUCT NDC: 17478-608
APPLICATION NUMBER: ANDA206719

Other BACITRACIN A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Bacitracin
Pharmacia and Upjohn Company LLCBacitracin